Adjuvant Global Health Technology Fund is a Private Equity Fund in New York with $178.57 mm assets under management, with a minimum investment of $5.00 mm. It has 20 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Industry
SEC CIK
AUM ?
$178.57 mm
Address
Adjuvant Global Health Technology Fund
C/O ADJUVANT CAPITAL, L.P.
445 5TH AVENUE, #20D
NEW YORK
NY 10016
C/O ADJUVANT CAPITAL, L.P.
445 5TH AVENUE, #20D
NEW YORK
NY 10016
Phone
917-334-0724
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Adjuvant Capital, LP | $347.45 mm | |
Adjuvant Global Health Technology Fund De, L.P. | $34.67 mm | Private Equity Fund |
Adjuvant Global Health Technology Fund, L.P. | $178.57 mm | Private Equity Fund |
Latest ownership filings
SC 13G/A
AN2 Therapeutics, Inc.
9 Feb 24
4
AN2 Therapeutics, Inc.
18 Jan 24
144
AN2 Therapeutics, Inc.
16 Jan 24
4
AN2 Therapeutics, Inc.
16 Nov 23
4
AN2 Therapeutics, Inc.
3 Oct 23
4
AN2 Therapeutics, Inc.
29 Sep 23
4
AN2 Therapeutics, Inc.
15 Sep 23
4
AN2 Therapeutics, Inc.
8 Sep 23
4
AN2 Therapeutics, Inc.
25 Aug 23
SC 13G
AN2 Therapeutics, Inc.
10 Feb 23